user-generated· event
Yosemite-backed Azalea reaches Phase 3 clinical trials by 2027-06-30
Azalea, a portfolio company of Yosemite Ventures born from Jennifer Doudna's lab, is developing a novel cancer therapy. With Yosemite's rapid advancements in oncology drug discovery and AI integration, Azalea is poised to advance to Phase 3 trials within 12 months, aligning with industry benchmarks for similar oncology programs.
event · Prediction Market
- Implied probability (Yes)
- 65%
- Closes
- 2027-06-30
More event markets
- Scottish government orders Higher Maths exam review by November 2027 — 75% Yes
- Chuck Edwards resigns before probe concludes — 70% Yes
- Sudan overtakes Syria as top country for conflict-driven internal displacement — 85% Yes
- Witkoff Rubio-Qatar Deal Collapses Due to Geopolitical Risks — 60% Yes
- Belgium advances past U.S. in World Cup Round of 16 — 70% Yes
- Kevin Kiley's petition fails to secure 218 signatures by end of 2026 — 65% Yes
- Frederica Wilson loses 2026 Florida primary bid — 62% Yes
- Eurovision bans Israel for 2028 due to ongoing Gaza conflict — 55% Yes
Loading…